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OC5.
GENISTEIN ACUTELY POTENTIATES ACETYLCHOLINE-
INDUCED RELAXATION THROUGH A G-PROTEIN
COUPLED PATHWAY IN SPONTANEOUSLY HYPERTENSIVE
RATS
AHY Lin, GPH Leung, SWS Leung, RYK Man
Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University
of Hong Kong, Hong Kong SAR, China
Objectives: Genistein, a phytoestrogen rich in soy beans and soy products,
was reported to be a vasorelaxant. This study examined the receptor and related
signaling pathways in the rapid vascular actions of genistein.
Methods: Isometric tension was measured in isolated aortic rings from 32-
weeks-old male spontaneously hypertensive rats (SHR).
Results: Acute exposure to genistein at 10 µM, a concentration with no direct
relaxation effect, potentiated acetylcholine (ACh)-induced relaxation and
reduced ACh-induced contraction in the presence of L-NAME (100 µM). Both
actions were insensitive to 10 µM actinomycin D (transcription inhibitor) and
10 µM cycloheximide (translation inhibitor). The potentiation of ACh-induced
relaxation by genistein in the absence or presence of indomethacin was
inhibited by 10 µM NF023 and 10 µM GP antagonist-2A, the selective Gi and
Gq α-subunit antagonists, respectively, but not by 10 µM NF449, a selective
G
s
 α-subunit antagonist. Interestingly, NF023, NF449 and GP antagonist-2A
did not alter the inhibitory effect of genistein on ACh-induced contraction. To
further elucidate the mechanism of the vascular response given by genistein,
the involvement of G-proteins was inspected in A23187-induced relaxation
and contraction. NF023 and GP antagonist-2A, but not NF449 inhibited the
potentiating effect of genistein on A23187-induced relaxation in the presence
of indomethacin. Reduction of A23187-induced contraction by genistein was
unaffected by all three G-protein inhibitors.
Conclusion: These results demonstrate that rapid vascular actions of genistein
in modulating ACh-induced relaxation and contraction responses in SHR are
mediated by non-genomic pathways. Gαi and Gαq, but not Gαs, were involved
in the potentiating effect of genistein in ACh and A23187-induced relaxations,
but none were involved in the inhibitory effect of genistein in ACh and A23187-
induced contractions. Involvement of G-proteins in the enhancement of ACh-
induced relaxation by genistein suggests that genistein exerts its effect through
a putative G-protein coupled phytoestrogen receptor.
OC6.
ESTROGEN SUPPRESSES THE CA2+/CALMODULIN-
DEPENDENT PROTEIN KINASE II THUS CONFERRING
CARDIOPROTECTION
Y Ma, WT Cheng, S Wu, TM Wong
Department of Physiology, The University of Hong Kong, Hong Kong SAR,
China
Estrogen confers cardioprotection by down-regulating β1-adrenoceptor and
suppressing the expression and activity of protein kinase A. We hypothesized
that estrogen may also protect the heart by suppressing the Ca2+/calmodulin-
dependent protein kinase II (CaMKII), another signaling messenger activated
by β1-adrenoceptor via the Gs protein that enhances apoptosis. We first
determined the expression of CaMKII in the heart of sham operated rats and
ovariectomized rats with and without estrogen replacement. Both CaMKIIδ
and phosphorylated CaMKII were up-regulated in the heart from
ovariectomized rats, which was restored to normal by estrogen replacement.
We then determined the injury and contractile responses to ischemic insult
with or without β-adrenoceptor stimulation with isoprenaline (10-7M) in
isolated perfused hearts and isolated ventricular myocytes. The infarct size
and lactate dehydrogenase release from the heart in response to ischemic
insult were significantly greater after ovariectomy. Similarly the cardiac
contractility, the amplitude of the electrically induced intracellular Ca2+
transient, which is directly correlated to the shortening of the myocyte, and
TUNEL-positive cells, were also greater in the ovariectomized rats upon
ischemia/reperfusion in the presence or absence of isoprenaline. Most
importantly, the responses to ischemic insult in ovariectomized rats were
reversed not only by estrogen replacement, but also by blockade of CaMKII
with a selective inhibitor, KN93 (2.5 µM). The observations indicated that
estrogen confers cardioprotection by suppressing the CaMKII. The CaMKII
isoform involved may be CaMKIIδ. The effect of estrogen on CaMKII is
independent of β-adrenoceptor in addition to its effect of down-regulating
the receptor.
